This will be a relief for the ASX compliance dudes - they won't have to make spitballing sh!t up to suspend the CBA for grand scale non disclosure. Look forward to the price sensitive announcement later this morning.
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status